|
Volumn 350, Issue , 2015, Pages
|
Type 2 diabetes and risk of cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SOMATOMEDIN C;
BILE DUCT CARCINOMA;
BREAST CANCER;
CANCER INCIDENCE;
CANCER MORTALITY;
CANCER RISK;
CANCER SURVIVAL;
CHRONIC INFLAMMATION;
COLORECTAL CANCER;
CONSENSUS DEVELOPMENT;
DATA ANALYSIS;
DISEASE ASSOCIATION;
DISEASE DURATION;
DISEASE SEVERITY;
EDITORIAL;
ENDOCRINE DISEASE;
ENDOMETRIUM CANCER;
EVIDENCE BASED MEDICINE;
GENETIC HETEROGENEITY;
HUMAN;
HYPERGLYCEMIA;
HYPERINSULINEMIA;
INSULIN BLOOD LEVEL;
INSULIN RESISTANCE;
LIVER CELL CARCINOMA;
MALIGNANT NEOPLASTIC DISEASE;
MEDICAL RESEARCH;
MEDICAL SOCIETY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS CANCER;
PHENOTYPIC VARIATION;
PREDICTIVE VALIDITY;
PROSTATE CANCER;
COMPLICATION;
DIABETES COMPLICATIONS;
FEMALE;
NEOPLASMS;
DIABETES COMPLICATIONS;
DIABETES MELLITUS, TYPE 2;
FEMALE;
HUMANS;
NEOPLASMS;
|
EID: 84920829322
PISSN: 09598146
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.g7707 Document Type: Editorial |
Times cited : (34)
|
References (10)
|